Analgesics Market in Pakistan to 2014 (OTC Healthcare)

Introduction

This databook provides key data and information on the Analgesics Market in Pakistan (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

*Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
*Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights


The analgesics category was valued at PKR6,718.2m ($95.4m) in 2009, representing a CAGR of 6.4% since 2004.

By the end of 2014, the analgesics category will be worth PKR8,539m ($121.3m), with an expected CAGR of 4.9% between 2009 and 2014.

The analgesics market was led by other analgesics (representing 75.2% of the total value) followed by ibuprofen and paracetamol, with an 11.7% and 8.4% market share, respectively. Aspirin accounts for the remaining 4.7% share.

Novartis AG is the market leader with a 24.7% share of the market.


Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the Analgesics Market in Pakistan (OTC Healthcare)

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: analgesics 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Analgesics 8
Value analysis (Pakistan Rupee), 2004?09 8
Value analysis (Pakistan Rupee), 2009?14 9
Value analysis (US dollars), 2004?09 11
Value analysis (US dollars), 2009?14 11
Company and brand share analysis 13
Distribution analysis 16
Chapter 4 Macroeconomic Profile 18
Macroeconomic Indicators 18
Chapter 5 Research Methodology 22
Methodology overview 22
Secondary research 23
Market modeling 24
Creating an initial data model 24
Revising the initial data model 24
Creating a final estimate 25
Creating demographic value splits 25
Primary research 25
Data finalization 26
Ongoing research 26

LIST OF FIGURES
Figure 1: Analgesics, Pakistan, value by segment (PKRm), 2004?14 10
Figure 2: Analgesics, Pakistan, category growth comparison, by value, 2004?14 12
Figure 3: Analgesics, Pakistan, company share by value (%), 2008?09 14
Figure 4: Analgesics, Pakistan, distribution channels by value (%), 2008?09 17
Figure 5: Annual data review process 23

LIST OF TABLES
Table 1: Analgesics category definitions 3
Table 2: Analgesics distribution channels 4
Table 3: Analgesics, Pakistan, value by segment (PKRm), 2004?09 8
Table 4: Analgesics, Pakistan, value forecast by segment (PKRm), 2009?14 9
Table 5: Analgesics, Pakistan, value by segment ($m), 2004?09 11
Table 6: Analgesics, Pakistan, value forecast by segment ($m), 2009?14 11
Table 7: Analgesics, Pakistan, brand share by value (%), 2008?09 13
Table 8: Analgesics, Pakistan, value by brand (PKRm), 2008?09 13
Table 9: Analgesics, Pakistan, company share by value (%), 2008?09 15
Table 10: Analgesics, Pakistan, value by company (PKRm), 2008?09 15
Table 11: Analgesics, Pakistan, distribution channels by value (%), 2008?09 16
Table 12: Analgesics, Pakistan, value by distribution channel (PKRm), 2008?09 16
Table 13: Pakistan population, by age group, 2004?09 (millions) 18
Table 14: Pakistan population forecast, by age group, 2009?14 (millions) 19
Table 15: Pakistan population, by gender, 2004?09 (millions) 19
Table 16: Pakistan population forecast, by gender, 2009?14 (millions) 20
Table 17: Pakistan nominal GDP, 2004?09 (PKRbn, nominal prices) 20
Table 18: Pakistan real GDP, 2004?09 (PKRbn, 2000 prices) 20
Table 19: Pakistan real GDP, 2004?09 ($bn, 2000 prices) 21
Table 20: Pakistan consumer price index, 2004?09 (2000=100) 21


[Inhaltsverzeichnis ausblenden]